$ZLTQ (ZELTIQ Aesthetics, Inc.)

$ZLTQ {{ '2016-04-26T20:04:51+0000' | timeago}} • Announcement

$ZLTQ said David Endicott has joined its BoD. Mr. Endicott currently serves on $OREX's BoD and as a member of the BoD for AdvaMed, the principal industry association for medical devices. Concurrent with Mr. Endicott's appointment, Dr. Bryan Roberts advised $ZLTQ that he will not be standing for reelection to the BoD at the upcoming annual meeting.

$MDT {{ '2018-01-16T17:16:57+0000' | timeago}} • Announcement

$MDT received FDA clearance of the Riptide Aspiration System, adding a valuable tool to the Acute Ischemic Stroke (AIS) product portfolio. This is designed to retrieve thrombus (or blood clot) through the Arc Catheter and restore blood flow in patients experiencing blockage of an artery in the brain, known as an ischemic stroke.

$HOLX {{ '2018-01-16T13:05:50+0000' | timeago}} • Announcement

$HOLX said its CE-marked Aptima HIV-1 Quant Dx assay has been awarded World Health Organization (WHO) prequalification for in vitro diagnostic. The Aptima HIV-1 Quant Dx assay is the first HIV-1 viral load assay with a dual claim for both diagnosis and treatment monitoring.

$HOLX {{ '2018-01-11T21:23:15+0000' | timeago}} • Announcement

Medical technology company $HOLX has elected Namal Nawana to its board of directors, effective immediately. Nawana was formerly the CEO of Alere, Inc. Prior to that, he served Johnson & Johnson in various leadership roles, including Worldwide President of DePuy Synthes Spine.

$MDT {{ '2018-01-10T14:44:35+0000' | timeago}} • Announcement

The FDA has approved an innovative clinician programmer for the SynchroMed-II Intrathecal Drug Delivery system developed by medical technology company $MDT, for chronic pain and spasticity. SynchroMed-II, an implantable pump, delivers medication directly to the fluid around the spinal cord. It is an app that facilitates simple, guided workflows.

$CUTR {{ '2018-01-08T18:33:07+0000' | timeago}} • Announcement

$CUTR introduced Juliet and Secret RF to its product offerings of laser and energy-based devices. The Juliet laser is intended for treatment in the area of women’s health. Secret RF is a new fractional radio frequency microneedling device that effectively remodels collagen, improves mild wrinkles, and diminishes scars.

$HOLX {{ '2018-01-08T13:10:32+0000' | timeago}} • Announcement

Medical technology company $HOLX said it is currently looking for net revenues of about $791MM for the first quarter of 2018, higher than $775MM-$790MM the company had estimated earlier. The latest guidance represents an 8% YoY growth, reflecting the effect of divestiture of Hologic’s blood screening business and acquisition of Cynosure.

$HOLX {{ '2018-01-03T13:10:03+0000' | timeago}} • Announcement

$HOLX said the MyoSure MANUAL device, which was designed to simplify tissue removal procedures regardless of setting, has received CE mark in Europe. The MyoSure MANUAL device joins the MyoSure suite of gynecologic surgical products that offer simple and effective solutions to resect and remove tissue.

$ZBH {{ '2017-12-19T14:31:26+0000' | timeago}} • Announcement

$ZBH appointed Bryan Hanson as President and CEO and a member of the BoD, effective Dec. 19, 2017. Daniel Florin, who has served as Interim CEO since July 11, 2017, will continue in his role as SVP and CFO. Most recently, Hanson served as a $MDT's Executive Committee member and as EVP and President of Medtronic's Minimally Invasive Therapies Group.

$MDT {{ '2017-12-19T14:11:39+0000' | timeago}} • Announcement

$MDT has named Bob White, previously SVP and President of APAC Region, as EVP and President of Minimally Invasive Therapies Group. The company also announced Chris Lee, SVP and President of Greater China Region, will assume the position of APAC Region President. These leadership changes are effective immediately.

$CNMD {{ '2017-12-14T12:14:54+0000' | timeago}} • Announcement

$CNMD said it will begin trading ex-dividend on Dec. 14, 2017. The company's BoD declared a cash dividend of $0.2 per share that is scheduled to be paid on Jan. 5, 2018. This is the 17th quarter that the company has paid the same dividend.

$MDT {{ '2017-12-08T21:21:14+0000' | timeago}} • Announcement

$MDT BoD approved 3Q18 cash dividend of $0.46 per ordinary share, representing a 7% increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in June 2017.

$VAR {{ '2017-12-07T15:05:38+0000' | timeago}} • Announcement

Medical devices maker $VAR said it received ANVISA registration for its cancer treatment device Halcyon in Brazil. The registration allows the company to market the new system in the Latin American country. Halcyon is designed to simplify operations and save time without compromising on quality.

$HOLX {{ '2017-11-27T12:28:43+0000' | timeago}} • Announcement

Medical technology company $HOLX has signed a development and distribution agreement with Clarius Mobile Health, a manufacturer of ultrasound scanners, for supply of handheld wireless scanners. The devices will be used for early detection of breast cancer. The company did not disclose the financial terms of the agreement.

$MDT {{ '2017-11-22T20:29:59+0000' | timeago}} • Webcast

In Oct., Animas announced to cease the manufacture and sale of its insulin pumps and partnered with $MDT to offer its customers the opportunity to transfer to a new device.With $JNJ exiting the insulin pump market in the US and Canada, $MDT now has access to the 90,000 patients who use Animas insulin pumps.

$MDT {{ '2017-11-22T20:27:57+0000' | timeago}} • Webcast

$MDT got US FDA approval for its MiniMed 670G hybrid closed-loop system and rolled the device out in a Priority Access program. It began shipping systems to patients in June. The company now expects growth to significantly improve in 3Q18 as it has finished shipping pumps for the program.

$MDT {{ '2017-11-21T17:06:41+0000' | timeago}} • Announcement

Given the recent events of hurricanes and wildfires, $MDT managed to restrict its revenue decline to just 4% for 2Q18. The medical-device maker saw its profit grow 81% on a GAAP basis. On adjusted basis, earnings fell 4% to $1.07 per share.

$MDT {{ '2017-11-21T12:59:44+0000' | timeago}} • Infographic

$MDT Medtronic plc Earnings AlphaGraphic: Q2 2018 Highlights

$HOLX {{ '2017-11-09T15:40:48+0000' | timeago}} • Announcement

For FY18, $HOLX expects revenue to be $3.20-3.28Bil, GAAP EPS to be $1.22-1.27 and non-GAAP EPS is estimated to be $2.10-2.15. For 1Q18, revenue is estimated to be $775-790MM, GAAP EPS to be $0.25-0.27 and non-GAAP EPS is targeted $0.48-0.50.

$HOLX {{ '2017-11-09T15:34:46+0000' | timeago}} • Announcement

$HOLX's profit dropped 10% in its final quarter of FY17 despite a 11% increase in the revenue. Net income was $83MM or $0.29 per share on revenues of $803MM. On a non-GAAP basis, Hologic earned $0.50 per share.

$MDT {{ '2017-11-09T13:05:42+0000' | timeago}} • Announcement

Preliminary 2Q18 Results: $MDT worldwide revenue declined 4% to approx. $7.05Bil, with the decline driven by the company's divestiture of its Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses to $CAH. The company expects the impact of Hurricane Maria to be approx. $0.03 to non-GAAP EPS for 2Q18.

Recent Transcripts

MDT (Medtronic plc)
Tuesday, November 21 2017 - 1:00pm
INFU (InfuSystem Holdings, Inc.)
Friday, November 10 2017 - 4:00pm
ONVO (Organovo Holdings, Inc.)
Thursday, November 9 2017 - 10:00pm
RMTI (Rockwell Medical, Inc.)
Wednesday, November 8 2017 - 9:30pm
HOLX (Hologic Inc.)
Wednesday, November 8 2017 - 9:30pm
ELMD (Electromed, Inc.)
Wednesday, November 8 2017 - 2:00pm
NAVB (Navidea Biopharmaceuticals, Inc)
Wednesday, November 8 2017 - 1:30pm
CUTR (Cutera, Inc.)
Tuesday, November 7 2017 - 9:30pm
VRX (Valeant Pharmaceuticals International, Inc.)
Tuesday, November 7 2017 - 1:00pm
DRAD (Digirad Corporation)
Friday, November 3 2017 - 3:00pm
IRIX (IRIDEX Corporation)
Thursday, November 2 2017 - 9:00pm
CNMD (CONMED Corporation)
Thursday, November 2 2017 - 8:30pm
VAR (Varian Medical Systems, Inc.)
Wednesday, October 25 2017 - 9:00pm
PTN (Palatin Technologies Inc.)
Monday, September 25 2017 - 3:00pm
ELMD (Electromed, Inc.)
Wednesday, September 6 2017 - 1:00pm
MDT (Medtronic plc)
Tuesday, August 22 2017 - 12:00pm
ONVO (Organovo Holdings, Inc.)
Wednesday, August 9 2017 - 9:00pm
RMTI (Rockwell Medical, Inc.)
Wednesday, August 9 2017 - 8:30pm
INFU (InfuSystem Holdings, Inc.)
Wednesday, August 9 2017 - 8:30pm
NAVB (Navidea Biopharmaceuticals, Inc)
Wednesday, August 9 2017 - 12:00pm

AlphaGraphics you may like